Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 25;20(19):4753.
doi: 10.3390/ijms20194753.

Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study

Aline Hajj  1   2 , Sahar Obeid  3   4   5   6 , Saria Sahyoun  7 , Chadia Haddad  8 , Jocelyne Azar  9   10 , Lydia Rabbaa Khabbaz  11   12 , Souheil Hallit  13   14
Affiliations

Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study

Aline Hajj et al. Int J Mol Sci. .

Abstract

Objectives: To assess clinical and genetic factors affecting response to treatment in a sample of patients with schizophrenia (treatment-resistant patients versus treatment responders). We also aimed at examining if these factors are different when we consider two different resistance classifications (the positive and negative syndrome scale, PANSS and the brief psychiatric rating scale, BPRS).

Material and methods: A case-control study included treatment-resistant patients and good responders. Patients were stratified in two groups based on the established criteria for treatment-resistant schizophrenia using BPRS and PANSS. The study was approved by the ethical committees (references: CEHDF1017; HPC-017-2017) and all patients/legal representatives gave their written consent. Clinical factors were assessed. DNA was obtained using a buccal swab and genotyping for OPRM1, COMT, DRD2 et MTHFR genes using the Lightcycler® (Roche).

Results: Some discrepancies between the BPRS and PANSS definitions were noted in our study when assessing the patients' psychopathological symptoms and response to treatment. The multivariable analysis, taking the presence versus absence of treatment resistance as the dependent variable, showed that that family history of schizophrenia, university studies, time since the beginning of treatment and chlorpromazine equivalent dose as well as the COMT gene are associated with resistance to treatment. In addition, a gender-related difference was noted for COMT SNP; men with at least one Met allele were more prone to be resistant to treatment than Val/Val patients.

Conclusion: Uncovering the clinical and genetic factors associated with resistance to treatment could help us better treat our schizophrenic patients in a concept of personalized medicine.

Keywords: BPRS; COMT; DRD2; MTHFR; OPRM1; PANSS; resistance; response to treatment; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Leucht S., Davis J.M., Engel R.R., Kissling W., Kane J.M. Definitions of response and remission in schizophrenia: Recommendations for their use and their presentation. Acta Psychiatr. Scand. Suppl. 2009:7–14. doi: 10.1111/j.1600-0447.2008.01308.x. - DOI - PubMed
    1. Leucht S., Kane J.M., Etschel E., Kissling W., Hamann J., Engel R.R. Linking the panss, bprs, and cgi: Clinical implications. Neuropsychopharmacology. 2006;31:2318–2325. doi: 10.1038/sj.npp.1301147. - DOI - PubMed
    1. Kennedy J.L., Altar C.A., Taylor D.L., Degtiar I., Hornberger J.C. The social and economic burden of treatment-resistant schizophrenia: A systematic literature review. Int. Clin. Psychopharmacol. 2014;29:63–76. doi: 10.1097/YIC.0b013e32836508e6. - DOI - PubMed
    1. Nucifora F.C., Jr., Woznica E., Lee B.J., Cascella N., Sawa A. Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives. Neurobiol. Dis. 2018 doi: 10.1016/j.nbd.2018.08.016. - DOI - PMC - PubMed
    1. Terzic T., Kastelic M., Dolzan V., Plesnicar B.K. Influence of 5-ht1a and 5-httlpr genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia. Neuropsychiatr. Dis. Treat. 2015;11:453–459. - PMC - PubMed

Substances